RBC Capital analyst Sabahat Khan maintained a Buy rating on Republic Services (RSG – Research Report) on January 27 and set a price target of

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

Swatch Group AG (UHR:SW) (OTC: OTC:SWGAY) shares were downgraded by Morgan Stanley (NYSE:MS) from Equalweight to Underweight. The firm also reduced the price target to CHF145.00 from the previous CHF175.

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the presidency. Morgan Stanley has notched a 17% gain. Investors have a dinner plate to choose from to explain the bullishness.

RBC Capital analyst Brad Heffern maintained a Hold rating on UDR (UDR – Research Report) today and set a price target of $43.00. The company’s

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $32.73 which represents a slight increase of $0.35 or 1.08% from the prior close of $32.38. The stock opened at $32.92 and touched a low of $32.

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record.

“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...

NextEra Energy (NYSE:NEE – Free Report) had its price target upped by Morgan Stanley from $93.00 to $94.00 in a research report report published on Thursday,Benzinga reports. Morgan Stanley currently has an overweight rating on the utilities provider’s stock.

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets

With Tesla set to release its latest quarterly earnings report, Wall Street thinks the stock can keep rising on a "golden age" for automation and AI.

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $13.67 which represents a decrease of $-0.05 or -0.36% from the prior close of $13.72. The stock opened at $13.74 and touched a low of $13.